BlueRock
Latest
Bayer claims early lead in Parkinson’s stem cell therapy
By Ludwig Burger FRANKFURT, June 28 (Reuters) - Bayer subsidiary BlueRock has become the first company to report initial success treating Parkinson's disease in humans using an experimental stem cell…